Early antiretroviral therapy during primary HIV-1 infection results in a transient reduction of the viral setpoint upon treatment interruption

Wyl, Viktor von; Gianella, Sara; Fischer, Marek; Niederoest, Barbara; Kuster, Herbert; Battegay, Manuel; Bernasconi, Enos; Cavassini, Matthias; Rauch, Andri; Hirschel, Bernard; Vernazza, Pietro; Weber, Rainer; Joos, Beda; Günthard, Huldrych F; Swiss HIV Cohort Study-SHCS, (2011). Early antiretroviral therapy during primary HIV-1 infection results in a transient reduction of the viral setpoint upon treatment interruption. PLoS ONE, 6(11), e27463. Lawrence, Kans.: Public Library of Science 10.1371/journal.pone.0027463

[img]
Preview
Text
journal.pone.0027463.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (458kB) | Preview

Long-term benefits of combination antiretroviral therapy (cART) initiation during primary HIV-1 infection are debated.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Infectiology

UniBE Contributor:

Rauch, Andri

ISSN:

1932-6203

Publisher:

Public Library of Science

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:24

Last Modified:

06 Aug 2015 09:20

Publisher DOI:

10.1371/journal.pone.0027463

PubMed ID:

22102898

Web of Science ID:

000297555300023

BORIS DOI:

10.7892/boris.8264

URI:

https://boris.unibe.ch/id/eprint/8264 (FactScience: 213780)

Actions (login required)

Edit item Edit item
Provide Feedback